s6y
Company name or ticker
Search
Neumora Therapeutics, Inc.
DRSLTR
Correspondence Related to Draft Registration Statement
Filed
Friday, February 11, 2022
Accession number
0000950123-22-002278
Documents
filename1.htm
DRSLTR
On sec.gov
Filing index
All files
Complete submission text
SGML header